abstract |
The invention relates to the production of human tissue activator (mPa) without contaminants, which is usually bound to its natural cellular environment. The human t-cell is produced in a significant amount by the recombinant DNA (pdnk) technology. The invention also relates to the methods, expression vectors and various host cells required for its production. |